Hospital readmissions, hospital readmissions. So much research with such uncertain overall results, but much of which continues to point to serious problems with the CMS and other punitive programs aimed at reducing inappropriate readmissions. A study reported in the Journal of the American Medical Association does little to ameliorate the concern that these programs are ill-designed to achieve their objectives. (JAMA Article) This study examined the relationship between all-cause risk-standardized 30-day hospital readmission rates and 30-day all-cause, risk standardized mortality rates for Medicare beneficiaries between 2005 and 2008. The index admission diagnoses were acute heart attack, heart failure and pneumonia. The theory being tested is that hospitals with more readmissions are probably delivering less quality and therefore have higher mortality rates. The researchers found that the average mortality rate and readmission rate was 16.6% and 19.9%, respectively, for heart attack, 11.2% and 24.6% for heart failure and 11.6% and 18.2% for pneumonia. In an analysis of the covariation, the researchers found no significant correlation between mortality and readmissions for heart attack and pneumonia and only a very weak one for heart failure. No difference was found according to various characteristics of hospitals. Some comfort can be taken in that it would appear that hospitals can lower readmissions without necessarily raising mortality, but at least according to one common measure of quality–mortality rates– there is no reason to think that lowering readmissions will improve that measure.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Racist Anti-racists Are All About the Money
September 16, 2024
Racist Anti-racists Are All About the Money
Anti-racism is an industry that makes a lot of white people very rich.
Commentary
Weekly US Debt Auctions
September 16, 2024
Weekly US Debt Auctions
The ever-increasing pile of US debt makes tracking debt auction results very important.
Commentary
An Outstanding but Relatively Unknown Writer, Charles McCarry
September 14, 2024
An Outstanding but Relatively Unknown Writer, Charles McCarry
The author Charles McCarry was an outstanding writer and prescient in his understanding of what…